Balixafortide Uses, Dosage, Side Effects and more
Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).
| Trade Name | Balixafortide |
| Generic | Balixafortide |
| Balixafortide Other Names | Balixafortide |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
